Alixandria Keller
Physician Assistant · Phoenix, AZNPI 1720607690
Payments from drug & device makers
Across 128 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$659
- Dendreon Pharmaceuticals LLC$513
- Pfizer$417
- C. R. Bard, Inc. & Subsidiaries$178
- 180 Medical, Inc.$165
- Progenics Pharmaceuticals, Inc.$159
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,02297%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $659 |
| Dendreon Pharmaceuticals LLC | 19 | $513 |
| Pfizer | 20 | $417 |
| C. R. Bard, Inc. & Subsidiaries | 10 | $178 |
| 180 Medical, Inc. | 6 | $165 |
| Progenics Pharmaceuticals, Inc. | 7 | $159 |
| Merck | 6 | $137 |
| Astellas Pharma US Inc | 8 | $130 |
| Rochester Medical Corporation | 5 | $92 |
| Antares Pharma, Inc. | 4 | $86 |
| Tolmar Pharmaceuticals, Inc. | 3 | $73 |
| Blue Earth Diagnostics | 3 | $62 |
| Myovant Sciences Inc. | 3 | $56 |
| Endo Pharmaceuticals Inc. | 4 | $53 |
| Olympus America Inc. | 3 | $49 |
| AbbVie | 2 | $48 |
| Urogen Pharma, Inc. | 3 | $47 |
| Johnson & Johnson | 2 | $31 |
| Bayer | 2 | $29 |
| Novartis | 1 | $26 |
| Hollister Incorporated | 1 | $22 |
| Tolmar, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Convatec Inc. | 1 | $14 |
| Halozyme Inc | 1 | $13 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,107 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 16 | $240,197 |
| XtandiEnzalutamide | 11 | $158,454 |
| MyrbetriqMirabegron | 14 | $11,735 |
| GemtesaVibegron | 15 | $7,390 |
| Tamsulosin Hcl | 36 | $485 |
| Tadalafil | 17 | $377 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $323 |
| Finasteride | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $31 | $240,19716 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $130 | $170,18825 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $659 | $7,39015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Phoenix
- Alyssa BoschenPhoenix$86K
- Katherine MinorPhoenix$76K
- Micah LasleyPhoenix$52K
- Thomas SirrinePhoenix$37K
- Karla HortonPhoenix$36K
- Larissa AnthonyPhoenix$32K
- Tana FrumentoPhoenix$25K
- Rosemary SrisukPhoenix$17K
- John DorseyPhoenix$17K
- Kendall SmithPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.